Cabotegravir, sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the...
25 KB (1,916 words) - 21:37, 20 December 2023
Cabotegravir/rilpivirine, sold under the brand name Cabenuva, is a co-packaged antiretroviral medication for the treatment of HIV/AIDS. It contains cabotegravir...
15 KB (1,249 words) - 18:21, 10 March 2024
for two new antiretroviral (ARV) medicines, rilpivirine (Rekambys) and cabotegravir (Vocabria), to be used together for the treatment of people with human...
205 KB (21,147 words) - 15:45, 15 July 2024
risk through receptive vaginal sex. In December 2021, the FDA approved cabotegravir (Apretude), which is an injectable form of PrEP manufactured by ViiV...
76 KB (8,035 words) - 05:52, 13 July 2024
strand transfer inhibitors (INSTIs): dolutegravir (brand name Tivicay) cabotegravir (brand names Apretude [as a single agent indicated for PrEP]; and Vocabria/Cabenuva...
8 KB (606 words) - 00:27, 8 May 2024
[better source needed] Cabotegravir, developed by ViiV Healthcare, was approved in conjunction with rilpivirine by the FDA in January 2021 (cabotegravir/rilpivirine)...
6 KB (622 words) - 17:42, 23 December 2023
In the European Union, rilpivirine is approved in combination with cabotegravir for maintenance treatment of adults who have undetectable HIV levels...
19 KB (1,645 words) - 23:20, 7 June 2024
allele-mismatched unrelated donor Voxelotor Global Blood Therapeutics Inc sickle cell disease Cabotegravir ViiV Healthcare Co pre-exposure prophylaxis for HIV...
34 KB (180 words) - 22:09, 8 April 2024
evidence suggests using universal CAR NK cells against HIV Viruses portal Cabotegravir COVID-19 vaccine HIV Vaccine Trials Network World AIDS Vaccine Day Gray...
48 KB (5,619 words) - 14:40, 3 July 2024
HPTN 083 is a 2016 clinical trial which compares cabotegravir injections with oral use of Emtricitabine/tenofovir as pre-exposure prophylaxis ("PrEP")...
5 KB (399 words) - 03:57, 27 September 2023
integrase inhibitors are elvitegravir, dolutegravir, bictegravir, and cabotegravir. Protease inhibitors block the viral protease enzyme necessary to produce...
134 KB (15,824 words) - 14:29, 11 April 2024
&. "Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV". www.prnewswire...
25 KB (1,860 words) - 23:03, 7 June 2024
absorption and high bioavailability. Cabenuva is approved by FDA as cabotegravir extended-release injectable nano-suspension, plus rilpivirine extended-release...
45 KB (5,275 words) - 16:28, 20 June 2024
inhibitors (Integrase strand transfer inhibitors (INSTI)) Bictegravir (BIC) Cabotegravir (CAB) Dolutegravir (DTG)# Elvitegravir (EVG) Raltegravir (RAL)# BI 224436†...
28 KB (2,986 words) - 19:14, 25 April 2024
dicyandiamide with it. Laufer claims that it can also be used to make naloxone, cabotegravir, mifepristone, and misoprostol. Jeremiah Johnson, a researcher at the...
12 KB (938 words) - 06:40, 15 May 2024
early proponent of using the combination of the integrase inhibitor, cabotegravir, and the non-nucleoside reverse transcriptase inhibitor, rilpivirine...
13 KB (1,573 words) - 06:10, 8 June 2024
Dovato lamivudine dolutegravir April 8, 2019 ViiV Healthcare Yes Cabenuva rilpivirine cabotegravir January 21, 2021 March 18, 2020 ViiV Healthcare No...
6 KB (111 words) - 16:33, 9 February 2024
Anti-retroviral Therapy: Orkin C, et al. (March 2020). "Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection". NEJM. 382...
19 KB (1,735 words) - 16:24, 15 June 2024
National Institute of Allergy and Infectious Diseases. "ViiV's long-acting cabotegravir outperforms daily pill in HIV trial". Clinical Trials Arena. 2020-07-08...
4 KB (381 words) - 21:23, 8 January 2024
whether injectable cabotegravir could be used for PrEP in people at greater risk of acquiring HIV. The study showed that cabotegravir was safe and well-tolerated...
31 KB (3,596 words) - 20:22, 4 June 2024
USAN) Cabenuva cabergoline (INN) cabiotraxetan (INN) Cablivi Cabometyx cabotegravir cabozantinib (USAN, INN) Cabtreo cactinomycin (INN) cadazolid (INN) cadexomer...
16 KB (757 words) - 05:06, 19 June 2024
combination therapy. This new treatment would consist of two drugs: cabotegravir and rilpivirine, and injections would occur every four to eight weeks...
45 KB (5,491 words) - 09:59, 21 June 2024
inhibitors (Integrase strand transfer inhibitors (INSTI)) Bictegravir (BIC) Cabotegravir (CAB) Dolutegravir (DTG)# Elvitegravir (EVG) Raltegravir (RAL)# BI 224436†...
3 KB (338 words) - 13:45, 27 July 2023
Brenda M. (August 2020). "A year-long extended release nanoformulated cabotegravir prodrug". Nature Materials. 19 (8): 910–920. Bibcode:2020NatMa..19..910K...
20 KB (1,766 words) - 20:13, 20 June 2024
J05AJ01 Raltegravir J05AJ02 Elvitegravir J05AJ03 Dolutegravir J05AJ04 Cabotegravir J05AP01 Ribavirin J05AP02 Telaprevir J05AP03 Boceprevir J05AP04 Faldaprevir...
6 KB (538 words) - 04:59, 18 December 2023
holds a study in conjunction with the Harvard AIDS Initiative to test cabotegravir injections to prevent HIV/AIDS. The African Chess Confederation appoints...
28 KB (2,592 words) - 21:59, 1 July 2024